MEDI-573, alone or in combination with mammalian target of rapamycin inhibitors, targets the insulin-like growth factor pathway in sarcomas

Molecular Cancer Therapeutics (2014) - Comment
pubmed: 25193511 doi: 10.1158/1535-7163.mct-14-0144 issn: 1538-8514 issn: 1535-7163

Haihong Zhong, Christine Fazenbaker, Shannon Breen, Cui Chen, Jiaqi Huang, Christopher Morehouse, Yihong Yao, Robert E. Hollingsworth